The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2017Join us in Harrogate 23rd to 26th July 2017
Antidepressants and SuicideProf Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Metabolic Guidelines ArticleArticle on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Dementia Guidelines MeetingClinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
New world order: Brexit, drugs and researchLetter to House of Commons Science and Technology Committee
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|16th March 2017||Child and Adolescent Psychopharmacology||Park Plaza Hotel, Maid Marian Way, Nottingham|
|21st March 2017||16th Latest Advances in Psychiatry Symposium||Royal College of Physicians, Regent’s Park, London|
|10th April 2017||BNA2017 Festival of Neuroscience||ICC, Birmingham|
Why isn’t there a gene for depression?
By Sarah Bailey
Posted on 14th November 2016
Dr Sarah Bailey, Senior Lecturer in Pharmacy and Pharmacology, University of Bath. Depression is sometimes categorised as a mental, rather than a physical illness –...
Donepezil and rhabdomyolysis – are you aware?
By Bharathi Balasundaram
Posted on 14th November 2016
Bharathi Balasundaram is a Consultant in Psycho Geriatrics, Changi General Hospital, Singapore. Acetylcholinesterase inhibitors (Donepezil, Rivastigmine and Galantamine) are used as cognitive enhancing agents in the management of patients with Alzheimer’s...
More Fish – Better Emotion and Better Attention
By Jane Pei-Chen Chang
Posted on 3rd November 2016
“Take Omega-3s, they are good for your mood…” “DHA is good for the developing brain…” So what are omega-3? We have seen them at nutritional supplement stores, we have seen them in...
Why schizophrenia need not rob us of a life in academia
Stephen is interviewed by the Guardian regarding working in academia with a mental illness
1st February 2017
Kanye West's travails help hip-hop open up on mental health
HipHopPsych was interviewed in guardian following Kanye West's hospitalisation
25th November 2016
Teens Reject Junk Food When Healthy Eating is Framed as Rebellion
Julia wrote an article for the British Psychological Society Research Digest about a new health intervention to make teenagers eat less junk food
20th October 2016
|Anti-Dementia Drugs Guidelines Updated |
20th January 2017
The third revision of BAP Guidelines, 'Clinical practice with anti-dementia drugs', are now available for download.
|ACMD report on Diversion and Illicit Supply of Medicines |
19th December 2016
BAP contributed evidence to the ACMD – Diversion & Illicit Supply of Medicines Inquiry
View letter and report
|British Medical Association (BMA) Research Grants 2017 |
16th December 2016
Applications are open 5th December from medical doctors or research scientists working in the UK for BMA research grants.
|Professor David Nutt receives honorary degree from Bath University |
8th December 2016
BAP warmly congratulates Professor David Nutt, who has been awarded Degree of Doctor of Laws, honoris causa, from Bath University.
Most recent articles:
Journal of Psychopharmacology, Volume 31, Issue 2, Page 147-168, February 2017.
Journal of Psychopharmacology, Volume 31, Issue 2, Page 169-183, February 2017.
Journal of Psychopharmacology, Volume 31, Issue 2, Page 184-191, February 2017.
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.